Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...

Dr. Albert Bourla is also troubled ... to even make those accusations.” Bourla understands those who are afraid of the vaccines — fear is human, he said. He suggested that a more comprehensive ...

Robert F. Kennedy Jr.'s nomination for Health and Human Services (HHS) secretary cleared a key Senate committee today. Should ...

Robert F. Kennedy had dinner with Pfizer CEO as he prepares to become health secretary, report says - Pfizer CEO certain that ...

Few CEOs know the double-edged nature of dealing with US President Donald Trump as viscerally as Pfizer’s Albert Bourla ... Warp Speed for cancer.” Bourla has not pitched the idea in those ...

SAN FRANCISCO — At the end of a roundtable lunch with a group of reporters, Pfizer CEO Albert ... not responded as he would like — Pfizer shares are down 5% over the past 12 months — Bourla ...

Albert Bourla, CEO of Pfizer since 2019, led the company through a global pandemic and rapidly developed and deployed a vaccine that was eventually taken by millions. That move alone nearly ...

Pfizer Chairman and CEO Albert Bourla did not mince his words at the 43rd annual ... s nominee to lead the Department of Health and Human Services but needs to be confirmed by the Senate.

Acquiring an injectable GLP-1 drug would not be in Pfizer's interest because "probably it's a little bit too late," Bourla said, referring to Wegovy and Zepbound's class of treatments that target ...

(JTA) — Albert Bourla, the chief executive officer of Pfizer, was named the winner of the 2022 Genesis Prize, the award sometimes called the “Jewish Nobel,” and pledged his winnings to ...

Pfizer Chief Executive Albert Bourla says recent Seagen acquisition provides "tremendous opportunity for growth." This interview was recorded on Jan. 15, 2024, at the World Economic Forum meeting ...

Pfizer is cutting costs and refocussing its research and development (R&D) operations in a bid to maintain and grow revenues in 2025, says CEO Albert Bourla. The company achieved its 2024 goal of ...